Natera, Inc.

NASDAQ:NTRA

106.1 (USD) • At close July 24, 2024
Bedrijfsnaam Natera, Inc.
Symbool NTRA
Munteenheid USD
Prijs 106.1
Beurswaarde 13,029,398,300
Dividendpercentage 0%
52-weken bereik 36.9 - 117.23
Industrie Diagnostics & Research
Sector Healthcare
CEO Mr. Steven Leonard Chapman
Website https://www.natera.com

An error occurred while fetching data.

Over Natera, Inc.

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene

Vergelijkbare Aandelen

Merit Medical Systems, Inc. logo

Merit Medical Systems, Inc.

MMSI

87 USD

LivaNova PLC logo

LivaNova PLC

LIVN

53.77 USD

Surgery Partners, Inc. logo

Surgery Partners, Inc.

SGRY

29.68 USD

Arrowhead Pharmaceuticals, Inc. logo

Arrowhead Pharmaceuticals, Inc.

ARWR

28.91 USD

CureVac N.V. logo

CureVac N.V.

CVAC

3.6 USD

Novavax, Inc. logo

Novavax, Inc.

NVAX

15.4 USD

Blueprint Medicines Corporation logo

Blueprint Medicines Corporation

BPMC

114.98 USD

Cytokinetics, Incorporated logo

Cytokinetics, Incorporated

CYTK

56.8 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)